ID   NPC43
AC   CVCL_UH64
DR   cancercelllines; CVCL_UH64
DR   Cell_Model_Passport; SIDM01992
DR   Wikidata; Q98128017
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=30405107;
CC   Population: Chinese.
CC   Virology: Contains 15-20 copies per cell of EBV genome.
CC   Doubling time: 8 days (Note=At 22th passage), 4 days (Note=At 90th passage), 2.5 days (Note=At 200th passage) (PubMed=30405107).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp53Ter (c.158G>A); ClinVar=VCV000230285; Zygosity=Homozygous (PubMed=30405107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
ST   Source(s): PubMed=30405107
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 13,15
ST   D21S11: 32
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 12,13
ST   D8S1179: 11
ST   FGA: 22
ST   Penta D: 8
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RA   Yip Y.-L., Lin W.-T., Deng W., Tsang C.-M., Tsao S.-W.;
RT   "Establishment of nasopharyngeal carcinoma cell lines, patient-derived
RT   xenografts, and immortalized nasopharyngeal epithelial cell lines for
RT   nasopharyngeal carcinoma and Epstein-Barr virus infection studies.";
RL   (In book chapter) Nasopharyngeal carcinoma. From etiology to clinical practice; Lee A.W.-M., Lung M.L., Ng W.T. (eds.); pp.85-107; Academic Press; New York; USA (2019).
//
RX   PubMed=30405107; DOI=10.1038/s41467-018-06889-5; PMCID=PMC6220246;
RA   Lin W.-T., Yip Y.-L., Jia L., Deng W., Zheng H., Dai W., Ko J.M.-Y.,
RA   Lo K.-W., Chung G.T.-Y., Yip K.Y.-L., Lee S.-D., Kwan J.S.-H., Zhang J.,
RA   Liu T.-F., Chan J.Y.-W., Kwong D.L.-W., Lee V.H.-F., Nicholls J.M.,
RA   Busson P., Liu X.-F., Chiang A.K.-S., Hui K.-F., Kwok H., Cheung S.-T.,
RA   Cheung Y.-C., Chan C.-K., Li B., Cheung A.L.-M., Hau P.-M., Zhou Y.,
RA   Tsang C.-M., Middeldorp J.M., Chen H.-L., Lung M.L., Tsao S.-W.;
RT   "Establishment and characterization of new tumor xenografts and cancer
RT   cell lines from EBV-positive nasopharyngeal carcinoma.";
RL   Nat. Commun. 9:4663.1-4663.17(2018).
//